Axios Vitals on MSN17h
Pharma eyes male birth control pill for Gen ZDrug developers are pursuing a new option for reproductive care in the post-Roe landscape: birth control pills for men. Why ...
Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...
The company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 ...
In Q2, it brought in $11.3 billion in sales, 36% higher than a year prior, and it cranked up its annual revenue guidance for ...
Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...
Live Mint on MSN10h
Piramal Pharma Solutions draws $80 mn expansion plan for injectables facility in USPiramal Pharma Solutions (PPS), the global contract manufacturing division of Piramal Pharma Ltd, is set to invest $80 ...
A new dark-money group called Americans for Pharma Reform has launched a multi-state bus tour to bring awareness to what they ...
(NASDAQ:THAR) ("Tharimmune"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, and Intract Pharma Ltd. ("Intract"), a ...
Mankind Pharma will issue non-convertible debentures (NCDs) and commercial papers (CP) worth ₹5,000 crore. These funds will ...
Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The board ...
The End the Vaccine Carveout Act, also called H.R. 9828, would get rid of liability shields for Big Pharma. “Although federal ...
As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback